MedTrace Logo

Improvement of Migraine Severity and Frequency With Migraineguard ™

NCT04759040 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2021-03-18

No results posted yet for this study

Summary

Numerous treatments have been recommended for the prevention of migraine. The purpose of this randomized double-blind placebo controlled trial was to assess the efficacy of MIGRAINEGUARD ™ supplement by Herbacure Natural containing a combination of COQ10 , magnesium, riboflavin ,feverfew , Skullcap and black pepper as prophylactic treatment for migraine.

Conditions

Interventions

DIETARY_SUPPLEMENT

Migraineguard

2 Capsules per day for 7 Months

Sponsors & Collaborators

  • Herbacure Natural

    lead INDUSTRY

Principal Investigators

  • AMIR A DOWLATSHAHI, PHD · HERBACURE NATURAL INC

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2020-10-31
Completion
2020-11-25

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04759040 on ClinicalTrials.gov